{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:57:39Z","timestamp":1782255459794,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000867","name":"Commonwealth Scholarship Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000867","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.gene.2021.145805","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T04:21:50Z","timestamp":1624940510000},"page":"145805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A review of the racial heterogeneity of breast cancer stem cells"],"prefix":"10.1016","volume":"796-797","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5215-4421","authenticated-orcid":false,"given":"Eric","family":"Gyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William K.B.A.","family":"Owiredu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Ahenkorah","family":"Fondjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganiyu A.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.gene.2021.145805_b0005","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra061808","article-title":"Cancer stem cells","volume":"355","author":"Jordan","year":"2006","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.gene.2021.145805_b0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mjafi.2016.02.010","article-title":"CD44 positive\/CD24 negative (stem cell like property) breast carcinoma cells as marker of tumor aggression","volume":"73","author":"Sen","year":"2017","journal-title":"Medical Journal Armed Forces India."},{"issue":"3","key":"10.1016\/j.gene.2021.145805_b0015","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s12032-010-9530-3","article-title":"The CD44+\/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients","volume":"28","author":"Giatromanolaki","year":"2011","journal-title":"Medical oncology (Northwood, London, England)."},{"issue":"3","key":"10.1016\/j.gene.2021.145805_b0020","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.humpath.2012.06.004","article-title":"Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity","volume":"44","author":"Currie","year":"2013","journal-title":"Hum Pathol."},{"issue":"25","key":"10.1016\/j.gene.2021.145805_b0025","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007171","article-title":"Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer","volume":"96","author":"Yao","year":"2017","journal-title":"Medicine."},{"issue":"1","key":"10.1016\/j.gene.2021.145805_b0030","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-015-0301-5","article-title":"Aldehyde dehydrogenase 1 expression correlates with the invasion of breast cancer","volume":"10","author":"Pan","year":"2015","journal-title":"Diagnostic pathology."},{"key":"10.1016\/j.gene.2021.145805_b0035","doi-asserted-by":"crossref","unstructured":"T. Yoshioka Y. Umekita Y. Ohi M. Souda Y. Sagara Y. Sagara Y. Sagara Y. Rai A. Tanimoto Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study 58 4 2011 608 616.","DOI":"10.1111\/j.1365-2559.2011.03781.x"},{"key":"10.1016\/j.gene.2021.145805_b0040","first-page":"81","article-title":"Features of CD44+\/CD24-low phenotypic cell distribution in relation to predictive markers and molecular subtypes of invasive ductal carcinoma of the breast","volume":"228","author":"Gudadze","year":"2014","journal-title":"Georgian medical news."},{"key":"10.1016\/j.gene.2021.145805_b0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yexmp.2019.05.001","article-title":"High GD2 expression defines breast cancer cells with enhanced invasiveness","volume":"109","author":"Mansoori","year":"2019","journal-title":"Experimental and molecular pathology."},{"issue":"7","key":"10.1016\/j.gene.2021.145805_b0050","first-page":"4173","article-title":"Expression of ALDH1 and TGF\u03b22 in benign and malignant breast tumors and their prognostic implications","volume":"7","author":"Zheng","year":"2014","journal-title":"International journal of clinical and experimental pathology."},{"issue":"7","key":"10.1016\/j.gene.2021.145805_b0055","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.humpath.2007.12.003","article-title":"The clinicopathologic and prognostic significance of CD44+\/CD24(-\/low) and CD44-\/CD24+ tumor cells in invasive breast carcinomas","volume":"39","author":"Mylona","year":"2008","journal-title":"Hum Pathol."},{"issue":"9","key":"10.1016\/j.gene.2021.145805_b0060","first-page":"11287","article-title":"Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma","volume":"8","author":"Chen","year":"2015","journal-title":"International journal of clinical and experimental pathology."},{"issue":"1","key":"10.1016\/j.gene.2021.145805_b0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.31768\/2312-8852.2015.37(1):58-63","article-title":"capital ES, CyrillicD44+\/CD24- markers of cancer stem cells in patients with breast cancer of different molecular subtypes","volume":"37","author":"Chekhun","year":"2015","journal-title":"Experimental oncology."},{"issue":"12","key":"10.1016\/j.gene.2021.145805_b0070","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.prp.2010.09.008","article-title":"The clinicopathological significance of CD44+\/CD24-\/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast","volume":"206","author":"Li","year":"2010","journal-title":"Pathology, research and practice."},{"issue":"1","key":"10.1016\/j.gene.2021.145805_b0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1756-9966-31-59","article-title":"CD44+\/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma","volume":"31","author":"Lin","year":"2012","journal-title":"Journal of experimental & clinical cancer research : CR."},{"issue":"1","key":"10.1016\/j.gene.2021.145805_b0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.breast.2010.08.001","article-title":"Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status","volume":"20","author":"Kim","year":"2011","journal-title":"The Breast."},{"issue":"5","key":"10.1016\/j.gene.2021.145805_b0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.breast.2004.02.010","article-title":"Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer","volume":"13","author":"Kim","year":"2004","journal-title":"Breast (Edinburgh, Scotland)."},{"issue":"9","key":"10.1016\/j.gene.2021.145805_b0090","doi-asserted-by":"crossref","first-page":"e43110","DOI":"10.1371\/journal.pone.0043110","article-title":"In Situ Identification of CD44+\/CD24\u2212 Cancer Cells in Primary Human Breast Carcinomas","volume":"7","author":"Perrone","year":"2012","journal-title":"PLOS ONE."},{"key":"10.1016\/j.gene.2021.145805_b0095","doi-asserted-by":"crossref","unstructured":"Althobiti M, El Ansari R, Aleskandarany M, et al. The prognostic significance of ALDH1A1 expression in early invasive breast cancer. 2020;n\/a(n\/a).","DOI":"10.1111\/his.14129"},{"issue":"2","key":"10.1016\/j.gene.2021.145805_b0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/sj.bjc.6605488","article-title":"Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer","volume":"102","author":"Nalwoga","year":"2010","journal-title":"Br J Cancer."},{"issue":"2","key":"10.1016\/j.gene.2021.145805_b0105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10549-016-3738-7","article-title":"Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype","volume":"156","author":"Kida","year":"2016","journal-title":"Breast cancer research and treatment."},{"key":"10.1016\/j.gene.2021.145805_b0110","doi-asserted-by":"crossref","unstructured":"Y. Ohi Y. Umekita T. Yoshioka M. Souda Y. Rai Y. Sagara Y. Sagara Y. Sagara A. Tanimoto Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer 59 4 2011 776 780.","DOI":"10.1111\/j.1365-2559.2011.03884.x"},{"issue":"3","key":"10.1016\/j.gene.2021.145805_b0115","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-020-05719-x","article-title":"The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes","volume":"182","author":"Althobiti","year":"2020","journal-title":"Breast cancer research and treatment."},{"key":"10.1016\/j.gene.2021.145805_b0120","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.ejca.2014.03.033","article-title":"OP0015 Immunohistochemical study of stem cell markers ALDH1 and BRCA1 in breast cancer","volume":"50","author":"Hosni","year":"2014","journal-title":"European Journal of Cancer."},{"issue":"5","key":"10.1016\/j.gene.2021.145805_b0125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.prp.2018.04.006","article-title":"ALDH1 and tumor infiltrating lymphocytes as predictors for neoadjuvant chemotherapy response in breast cancer","volume":"214","author":"Lee","year":"2018","journal-title":"Pathology \u2013 Research and Practice."},{"key":"10.1016\/j.gene.2021.145805_b0130","doi-asserted-by":"crossref","unstructured":"K. Morimoto S.J. Kim T. Tanei K. Shimazu Y. Tanji T. Taguchi Y. Tamaki N. Terada S. Noguchi Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression 100 6 2009 1062 1068.","DOI":"10.1111\/j.1349-7006.2009.01151.x"},{"key":"10.1016\/j.gene.2021.145805_b0135","doi-asserted-by":"crossref","unstructured":"I. Rabinovich L.d. Noronha A.P.M. Sebasti\u00e3o R.S. Lima C.A. Urban E. Schunemann J\u00fanior S. El\u00edfio-Esposito C.C. Spautz A.N. Moreno-Amaral HER2-expressing breast tumors are associated with breast cancer stem-cell phenotype CD44+\/CD24- 54 5 2018 10.5935\/1676-2444.20180052.","DOI":"10.5935\/1676-2444.20180052"},{"issue":"10","key":"10.1016\/j.gene.2021.145805_b0140","doi-asserted-by":"crossref","first-page":"e78259","DOI":"10.1371\/journal.pone.0078259","article-title":"Triple negative breast tumors in African-American and Hispanic\/Latina women are high in CD44+, low in CD24+, and have loss of PTEN","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One."},{"issue":"12","key":"10.1016\/j.gene.2021.145805_b0145","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1245\/s10434-015-4455-x","article-title":"Characterizing Breast Cancer in a Population with Increased Prevalence of Triple-Negative Breast Cancer: Androgen Receptor and ALDH1 Expression in Ghanaian Women","volume":"22","author":"Proctor","year":"2015","journal-title":"Annals of surgical oncology."},{"issue":"3","key":"10.1016\/j.gene.2021.145805_b0150","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/cncr.27737","article-title":"Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women","volume":"119","author":"Schwartz","year":"2013","journal-title":"Cancer."},{"issue":"2","key":"10.1016\/j.gene.2021.145805_b0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2014.06.022","article-title":"Enriched CD44+\/CD24\u2212 population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)","volume":"353","author":"Ma","year":"2014","journal-title":"Cancer letters."},{"issue":"4","key":"10.1016\/j.gene.2021.145805_b0160","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5301\/JBM.5000048","article-title":"Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer","volume":"28","author":"Li","year":"2013","journal-title":"The International journal of biological markers."},{"issue":"10","key":"10.1016\/j.gene.2021.145805_b0165","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.prp.2015.05.011","article-title":"The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44\/CD24 expression in breast cancer","volume":"211","author":"Kapucuo\u011flu","year":"2015","journal-title":"Pathology, research and practice."},{"issue":"11","key":"10.1016\/j.gene.2021.145805_b0170","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jcp.2011.090456","article-title":"Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype","volume":"64","author":"Ricardo","year":"2011","journal-title":"J Clin Pathol."},{"key":"10.1016\/j.gene.2021.145805_b0251","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151696","article-title":"The role of ALDH1A1 in contributing to breast tumour aggressiveness: A study conducted in an African population","volume":"51","author":"Gyan","year":"2021","journal-title":"Annals of Diagnostic Pathology"},{"issue":"3","key":"10.1016\/j.gene.2021.145805_b0175","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2108","article-title":"The CD44+\/CD24- phenotype is enriched in basal-like breast tumors","volume":"10","author":"Honeth","year":"2008","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.gene.2021.145805_b0180","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.humpath.2011.05.005","article-title":"CD44(+)\/CD24(-\/low) cancer stem\/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome","volume":"43","author":"Idowu","year":"2012","journal-title":"Hum Pathol."},{"key":"10.1016\/j.gene.2021.145805_b0185","first-page":"2943","article-title":"Cancer stem cell markers ALDH1 and CD44+\/CD24\u2013 phenotype and their prognosis impact in invasive ductal carcinoma","volume":"62","author":"Iris","year":"2018","journal-title":"European Journal of Histochemistry."},{"issue":"9","key":"10.1016\/j.gene.2021.145805_b0190","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.prp.2013.05.007","article-title":"The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis","volume":"209","author":"Dong","year":"2013","journal-title":"Pathology, research and practice."},{"issue":"3","key":"10.1016\/j.gene.2021.145805_b0195","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10549-011-1865-8","article-title":"A CD44(-)\/CD24(+) phenotype is a poor prognostic marker in early invasive breast cancer","volume":"133","author":"Ahmed","year":"2012","journal-title":"Breast cancer research and treatment."},{"issue":"5","key":"10.1016\/j.gene.2021.145805_b0200","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.2353\/ajpath.2010.090712","article-title":"In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis","volume":"176","author":"Neumeister","year":"2010","journal-title":"The American Journal of Pathology."},{"key":"10.1016\/j.gene.2021.145805_b0205","article-title":"Breast cancer stem cells in Africa: a fallow research ground","volume":"153118","author":"Gyan","year":"2020","journal-title":"Pathology \u2013 Research and Practice."},{"key":"10.1016\/j.gene.2021.145805_b0210","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","article-title":"Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue \u2013 a review","volume":"9","author":"Fedchenko","year":"2014","journal-title":"Diagnostic pathology."},{"issue":"2","key":"10.1016\/j.gene.2021.145805_b0215","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ajpath.2017.06.020","article-title":"Triple-Negative Breast Cancer, Stem Cells, and African Ancestry","volume":"188","author":"Jiagge","year":"2018","journal-title":"The American Journal of Pathology."},{"issue":"6","key":"10.1016\/j.gene.2021.145805_b0220","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/BF00731251","article-title":"Expression of \u03b12,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes","volume":"12","author":"Yamashiro","year":"1995","journal-title":"Glycoconjugate Journal."},{"issue":"7","key":"10.1016\/j.gene.2021.145805_b0225","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1134\/S0006297915070020","article-title":"Gangliosides in breast cancer: New perspectives","volume":"80","author":"Groux-Degroote","year":"2015","journal-title":"Biochemistry (Moscow)."},{"issue":"4","key":"10.1016\/j.gene.2021.145805_b0230","first-page":"548","volume":"120","author":"Roth","year":"2014","journal-title":"Ganglioside GD2 as a therapeutic target for antibody-mediated therapy in patients with osteosarcoma."},{"issue":"13","key":"10.1016\/j.gene.2021.145805_b0235","first-page":"3445","article-title":"Human monoclonal antibodies to glycolipids and other carbohydrate antigens: dissection of the humoral immune response in cancer patients","volume":"49","author":"Lloyd","year":"1989","journal-title":"Cancer research."},{"issue":"10","key":"10.1016\/j.gene.2021.145805_b0240","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1182\/blood-2006-08-039347","article-title":"Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs","volume":"109","author":"Martinez","year":"2007","journal-title":"Blood."},{"key":"10.1016\/j.gene.2021.145805_b0245","doi-asserted-by":"crossref","unstructured":"M. Mansoori A. Mirzai I. Abdi Rad R. MahmoodLu Z. Madjd Expression of Ganglioside GD2, as a Novel Cancer Stem Cell Marker in Breast Carcinomas %J Multidisciplinary Cancer Investigation. 1 Supplementary 1 2017 0 0.","DOI":"10.21859\/mci-supp-31"},{"issue":"1","key":"10.1016\/j.gene.2021.145805_b0250","doi-asserted-by":"crossref","first-page":"1683345","DOI":"10.1080\/2162402X.2019.1683345","article-title":"GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells","volume":"9","author":"Seitz","year":"2020","journal-title":"OncoImmunology."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111921004005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111921004005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:43:56Z","timestamp":1759855436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111921004005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":51,"alternative-id":["S0378111921004005"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2021.145805","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of the racial heterogeneity of breast cancer stem cells","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2021.145805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"145805"}}